Tortuga Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Tortuga Wealth Management's BMY Position: Q3 2026 in Review
Tortuga Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q3 2026, selling an estimated $92.6K and leaving 11,762 shares worth $734K. The position accounts for 0.52% of the portfolio, ranked #48.
Tortuga Wealth Management first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. The position peaked at $774K in Q1 2026. 2,074 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Tortuga Wealth Management held 11,762 shares of Bristol-Myers Squibb worth $734K as of Q3 2026.
- Tortuga Wealth Management sold 1,466 Bristol-Myers Squibb shares in Q3 2026, an estimated $92.6K.
- Bristol-Myers Squibb made up 0.52% of Tortuga Wealth Management's portfolio in Q3 2026, its #48 holding.
- Tortuga Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
- Tortuga Wealth Management's Bristol-Myers Squibb position peaked at $774K in Q1 2026.
- 2,074 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Tortuga Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.